Isan Chen
2018
In 2018, Isan Chen earned a total compensation of $1.7M as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics, a 128% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $252,300 |
|---|---|
| Option Awards | $1,040,832 |
| Salary | $420,500 |
| Other | $2,500 |
| Total | $1,716,132 |
Chen received $1M in option awards, accounting for 61% of the total pay in 2018.
Chen also received $252.3K in non-equity incentive plan, $420.5K in salary and $2.5K in other compensation.
Rankings
In 2018, Isan Chen's compensation ranked 6,499th out of 14,244 executives tracked by ExecPay. In other words, Chen earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,499 out of 14,244 | 54th |
Division Manufacturing | 2,485 out of 5,765 | 57th |
Major group Chemicals And Allied Products | 926 out of 2,128 | 57th |
Industry group Drugs | 778 out of 1,817 | 57th |
Industry Pharmaceutical Preparations | 606 out of 1,391 | 56th |
Source: SEC filing on April 19, 2019.
Chen's colleagues
We found four more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2018.